Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PROMAZINE HYDROCHLORIDE CRS (40 MG)

PROMAZINE HYDROCHLORIDE CRS (40 MG)

53-60-1

DISCOVER
PROMETHAZINE HYDROCHLORIDE CRS (50 MG)

PROMETHAZINE HYDROCHLORIDE CRS (50 MG)

58-33-3

DISCOVER
Pyrazinamide

Pyrazinamide

98-96-4

DISCOVER
PROPACETAMOL HYDROCHLORIDE - REFERENCE SPECTRUM (N/A)

PROPACETAMOL HYDROCHLORIDE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
PROPRANOLOL  HYDROCHLORIDE CRS (30 MG)

PROPRANOLOL HYDROCHLORIDE CRS (30 MG)

318-98-9

DISCOVER
Propranolol hydrochloride forperformance test

Propranolol hydrochloride forperformance test

318-98-9

DISCOVER
Propyphenazone

Propyphenazone

479-92-5

DISCOVER
Propyl gallate

Propyl gallate

121-79-9

DISCOVER
PROPYL PARAHYDROXYBENZOATE CRS (150 MG)

PROPYL PARAHYDROXYBENZOATE CRS (150 MG)

94-13-3

DISCOVER
Piperine

Piperine

94-62-2

DISCOVER
PROPYLTHIOURACIL CRS (30 MG)

PROPYLTHIOURACIL CRS (30 MG)

51-52-5

DISCOVER
Propafenone HCl

Propafenone HCl

34183-22-7

DISCOVER